Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial).

Popat, Rakesh, Brown, Sarah R, Flanagan, Louise, Hall, Andrew, Gregory, Walter, Kishore, Bhuvan, Streetly, Matthew, Oakervee, Heather, Yong, Kwee, Cook, Gordon, Low, Eric and Cavenagh, Jamie (2018) Extended follow-up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi-centre phase I/II Clinical Trial). British journal of haematology. ISSN 1365-2141. This article is available to all HEFT staff and students via ASK HEFT Discovery tool http://tinyurl.com/z795c8c using their HEFT Athens Login.

Full text not available from this repository.

Item Type:	Article
Additional Information:	This article is available to all HEFT staff and students via ASK HEFT Discovery tool http://tinyurl.com/z795c8c using their HEFT Athens Login.
Subjects:	WH Haemic and lymphatic systems. Haematology
Divisions:	Clinical Support > Pathology
Related URLs:	https://www.ncbi.nlm.nih.gov/pubmed/?ter...
Depositing User:	Mrs Semanti Chakraborty
Date Deposited:	24 Aug 2018 13:44
Last Modified:	24 Aug 2018 13:44
URI:	http://www.repository.uhblibrary.co.uk/id/eprint/1731

Actions (login required)

View Item